CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3

BACKGROUND: Natural killer/T-cell lymphoma (NKTCL) is a rare and aggressive subtype of Non-Hodgkin’s Lymphoma. CircRNA has shown great potential to become a biomarker in plasma. In this study, we aimed to determine circRNA for its diagnostic and prognostic value and biological function in NKTCL. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Mei, Wang, Yingjun, Song, Wenting, Li, Zhaoming, Wang, Qilong, Li, Jiayin, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567645/
https://www.ncbi.nlm.nih.gov/pubmed/34736477
http://dx.doi.org/10.1186/s12935-021-02296-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567645/
https://www.ncbi.nlm.nih.gov/pubmed/34736477
http://dx.doi.org/10.1186/s12935-021-02296-x

Ejemplares similares